Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Free
Message: AGORACOM Small Cap 60: Awakn Life Sciences Aims To Provide Hope For Individuals and Communities That Are Plagued By #Addiction

AGORACOM Small Cap 60: Awakn Life Sciences Aims To Provide Hope For Individuals and Communities That Are Plagued By #Addiction

posted on Feb 10, 2022 12:20AM

Share
New Message
Please login to post a reply